PW Medtech Group Limited (HKG:1358)

Market Cap	1.37B -38.2%
Revenue (ttm)	927.26M -4.9%
Net Income	49.72M -70.6%
EPS	0.03 -70.5%
Shares Out	1.43B
PE Ratio	28.76
Forward PE	n/a
Dividend	0.06 (6.85%)
Ex-Dividend Date	Nov 2, 2026

Volume	317,000
Open	0.9550
Previous Close	0.9750
Day's Range	0.9550 - 0.9800
52-Week Range	0.8750 - 1.6300
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 1,433
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1358

Financial Performance

In 2025, PW Medtech Group's revenue was 823.51 million, an increase of 7.10% compared to the previous year's 768.90 million. Earnings were 94.37 million, a decrease of -37.41%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error